We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Presents Full Portfolio of Quality Measurement Tools

By LabMedica International staff writers
Posted on 25 Jul 2023

LGC Clinical Diagnostics (Middlesex, UK) is showcasing its full portfolio of quality measurement tools at AACC 2023 with complete access to its sub-brands including Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. More...

LGC’s combined capabilities make it better positioned to support the needs of the clinical diagnostics industry, from early feasibility and research to commercial & laboratory development test (LDT) assay development, installation, validation, and ongoing performance monitoring support.

At AACC 2023, LGC is presenting VALIDATE linearity & calibration verification materials, ACCURUN reference materials & QC products, the Multichem range of independent quality controls, and the VirtuE range of antigens & antibodies. The VALIDATE ready-to-use kits from Maine Standards are designed to assist in the documentation of linearity, calibration verification, and verification of linear range required by many inspection agencies. VALIDATE also provides assistance when troubleshooting instrument systems, reagent problems, and calibration anomalies. LGC is also highlighting SeraCare’s ACCURUN controls and reference materials: which are designed to be weakly reactive to help monitor serology assays for additional confidence in laboratory test results. In addition, the Seraseq Next-generation sequencing (NGS) reference materials help scientists and clinicians build, validate, implement, and standardize better clinical genomics assays.

Visitors to the LGC booth at AACC 2023 can also learn more about the Multichem class-leading third-party test-consolidated QC product range from Technopath Clinical Diagnostics. The extensive list of analytes included in the Multichem product range guarantees quality, choice, and flexibility. Multichem ID controls can be used as part of the QConnect integrated and simplified QC solution. ​Also being highlighted by LGC at the show is the VirtuE range of antigens & antibodies from The Native Antigen Company that are produced using the company’s VirtuE mammalian expression system. These antigens are suitable for use in vaccine R&D, as components for serological-based diagnostic assays, and for fundamental research into infectious diseases.

Related Links:
LGC 


Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.